Volume 45, No. 3/2007(March)

Int. Journal of Clinical Pharmacology and Therapeutics
The online-version will be updated before the print-version of this Journal is published. Upon request we will send the password and user name by e-mail. The online-service is only available for subscribers of the print-version, if proof of purchase is submitted.

The use of the online-version will be charged with an extra fee (additional to the subscription of the print-version).
The service can be used until December 31st of the year of subscription.

Price of the complete print-issue: 26.00$ Add to Cart
Therapeutics Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration J.M. Conil, B. Georges, O. Fourcade, T. Seguin, G. Houin and S. Saivin Add to Cart
133
Therapeutics Isopropanolic black cohosh extract and recurrence-free survival after breast cancer H.H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz and H. Becher Add to Cart
143
Therapeutics Intraoperative small-dose ketamine does not reduce pain or analgesic consumption during perioperative opioid analgesia in children after tonsillectomy Y.K. Batra, M. Shamsah, M.J. Al-Khasti, H.J.F. Rawdhan, A.R. Al-Qattan and K.G. Belani Add to Cart
155
Molecular Target Therapy Transgenic avian-derived recombinant human interferon-a2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study T.B. Patel, E. Pequignot, S.H. Parker, M.C. Leavitt, H.E. Greenberg and W.K. Kraft Add to Cart
161
Drug Utilization Antimicrobial use at a university hospital: appropriate or misused? A qualitative study V. Vlahovic-Palcevski, I. Francetic, G. Palcevski, S. Novak, M. Abram and U. Bergman Add to Cart
169
Bioavailability Section A bioequivalence study of gliclazide based on quantification by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry G.D. Mendes, L.D. Moreira, A. dos S. Pereira, A. Borges, F. Yui, F.D. Mendes and G. de Nucci Add to Cart
175
Letters to the Editor Interaction between activated VD3 and Ca channel blockers in patients undergoing hemodialysis S. Negoro, S. Izumi, T. Furukubo, M. Satoh, C. Matsunaga, T. Yamakawa, S. Ikegawa, H. Nakanishi, D. Kadowaki and S. Hirata Add to Cart
186
Letters to the Editor Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem S. Padol, Y. Yuan, M. Thabane, I.T. Padol and R.H. Hunt Add to Cart
188
Letters to the Editor Reply to S. Padol et al. U. Klotz Add to Cart
189